Navigation Links
MultiCell Announces Results of Shareholders' Meeting
Date:8/14/2012

SAN DIEGO, Aug. 14, 2012 /PRNewswire/ -- MultiCell Technologies, Inc. (OTCBB: MCET.OB), a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer, announced the results from its annual shareholders meeting held Friday, August 10, 2012 in San Diego, CA.

Jerry Newmin, Chairman and CEO, welcomed attendees, introduced the board of directors, officers and guests, and conducted the meeting. Shareholders ratified all items on the proxy statement including:

  1. The election of Thomas A. Page, Stephen Chang, W. Gerald Newmin, Tony Altig and Edward Sigmond as Directors for a one-year term; 
  2. The ratification of Hanson, Barnett and Maxwell as independent public accountants; 
  3. An increase in the authorized shares of the company's common stock.

The results of the meeting can be found on Form 8-K that was filed with the SEC on August 13, 2012.

After the formal portion of the meeting, Martin Schroeder of the Emmes Group, consultant to MultiCell, discussed product development priorities and progress for the past year. Mr. Newmin addressed shareholder questions including the continuing efforts to build shareholder value.

For more information about MultiCell Technologies, please visit http://www.multicelltech.com.

Caution Regarding Forward-Looking Statements
Any statements in this press release about MultiCell's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). These statements are often, but not always, made through the use of words or phrases such as "believe", "will", "expect", "anticipate", "estimate", "intend", "plan", "forecast", "could", and "would". MultiCell bases these forward- looking statements on current expectations about future events. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections in the forward-looking statement include, but are not limited to, the risk that we might not achieve our anticipated clinical development milestones, receive regulatory approval, or successfully commercialize our products as expected, the market for our products will not grow as expected, and the risk that our products will not achieve expectations. For additional information about risks and uncertainties MultiCell faces, see documents that MultiCell files with the Securities and Exchange Commission, including MultiCell's report on Form 10-K for the fiscal year ended November 30, 2011, and all of MultiCell's quarterly and other periodic SEC filings. MultiCell claims the protection of the safe harbor for forward-looking statements under the Act and assumes no obligation and expressly disclaims any duty to update any forward-looking statement to reflect events or circumstances after the date of this news release or to reflect the occurrence of subsequent events.

 


'/>"/>
SOURCE MultiCell Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models
2. ChemAxon Announces New Version of chemicalize.org for Tablet PCs
3. Naturs Design Announces the Dreams With Hope Tour, a Nationwide Sleep Awareness Campaign
4. ADVENTRX Announces Appointment Of Chief Medical Officer
5. FDAnews Announces Medical Device Mobile Apps Virtual Conference
6. Dehaier Medical Announces 2012 Second Quarter and Six Month Financial Results
7. Isis Pharmaceuticals Announces Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027
8. WuXi PharmaTech Announces Second-Quarter 2012 Results
9. Varian Medical Systems CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
10. Comprehensive Care Corporation Announces Profitable Six Month Financial Results
11. Tactical Medical Packs Announces New Disaster Medical Packs Equipping First Responders for Mass Casualty Incidents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... International plc (NASDAQ: ENDP ) today announced ... network, the Company will be ceasing operations and closing ... Alabama . The closure of the facilities is ... 18 months. The Huntsville location ... and these restructuring actions are intended to better match ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based biotechnology company ... the completion of a $12.7 million Series A financing round. ... as the participation of existing investors. ... of New Ventures III and our current investors, and view ... of our platform technology to transform the course of PD ...
(Date:7/13/2017)... -- New York City-based market research firm Kalorama Information notes seven ... From new products to new costs, to the threat of ... study, Potential Pipeline Disruptors . Among them ... 1.  Age-Driven Growth - True Impact Moment Arriving   ... the growing population and, to a more extreme extent, the ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... selected to renovate and improve the Ramsey County Medical Examiners Facility located in ... Hospital, the $2.5 million project is scheduled to start in late 2017/early 2018. ...
(Date:7/21/2017)... ... 21, 2017 , ... The Margarian Law Firm has filed a class ... ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand of ... Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it is made ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... Tears® EyeMist®, the signature product of her research center at Bio-Logic Aqua Research® ... largest population and the greatest number of sufferers of blindness. “We think that ...
(Date:7/20/2017)... Aliso Viejo, CA (PRWEB) , ... July 20, 2017 , ... ... effect when placed between two clips in the FCPX timeline. This effect isolates horizontal ... Each transition in this package contains either a rotating or flipping animation and can ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended hospital stays or ... used in such facilities are specially designed to accommodate patients with a wide range ... An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, a specially ...
Breaking Medicine News(10 mins):